Search
KT-333
go.drugbank.com/drugs/DB17165InvestigationalKT-333 is a small molecule targeted protein degrader of STAT3.[L44086]
BI-836880
go.drugbank.com/drugs/DB17484InvestigationalBI-836880 is a humanized bispecific nanobody that targets VEGF and Ang2.
Atinumab
go.drugbank.com/drugs/DB17923InvestigationalATI-355 is a humanized anti-Nogo-A antibody developed by Novartis.
SGN-1
go.drugbank.com/drugs/DB18135InvestigationalSGN-1 is a genetically modified strain of _Salmonella enterica_ comprising methioninase.
IVT-8086
go.drugbank.com/drugs/DB18381ExperimentalIVT-8086 is a humanized secreted frizzled-related protein-2 monoclonal antibody.
EI-1071
go.drugbank.com/drugs/DB18486InvestigationalEI-1071 is a selective Colony Stimulating Factor-1 Receptor kinase inhibitor.
Sonesitatug Vedotin
go.drugbank.com/drugs/DB18619InvestigationalCMG901 is an anti-Claudin 18.2 monoclonal antibody conjugated with MMAE payload.
RO7284755
go.drugbank.com/drugs/DB17527InvestigationalRO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein. … RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And
Tulathromycin A
go.drugbank.com/drugs/DB11474ExperimentalVet approvedTulathromycin is a macrolide antibiotic used to treat bovine respiratory disease in cattle and swine respiratory disease in pigs. It is marketed by Pfizer Inc. under the tradename Draxxin.
Cycloleucine
go.drugbank.com/drugs/DB04620ExperimentalCycloleucine is non-metabolisable amino acid formed by cyclization of leucine. It is also a specific and reversible inhibitor of nucleic acid methylation and widely used in biochemical experiments.